Stocks · Health care · Pharmaceutical Preparations

Travere Therapeutics, Inc.

TVTX Clue Score50

United States Fiscal year ends December CIK 0001438533 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$110.40M

$10.19M on a plan · $98.70M straight out of an exercise

Sold at will

$1.51M

8 of 118 sales

Net

−$110.40M

−$1.51M against sales at will